FindTrial
Sign In

Research on nursing safety management of artificial liver treatment based on HFMEA

Research on nursing safety management of artificial liver treatment based on HFMEA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081450
Enrollment
Unknown
Registered
2024-03-01
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver failure

Interventions

Group of artificial liver treatment:None

Sponsors

The Third Affiliated Hospital of Sun Yat sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: ? Patients who are currently or have previously received artificial liver treatment; ? Individuals with stable medical conditions, clear consciousness, and the ability to read and answer questions correctly; ? Voluntarily participate in this survey and sign an informed consent form; ? Age = 18 years old.

Exclusion criteria

Exclusion criteria: ? Patients with gastrointestinal bleeding, mental illness, and concurrent intracranial lesions; ? Language communication barriers.

Design outcomes

Primary

MeasureTime frame
vital signs;Disease observation;Blood routine ;coagulation tests;—

Countries

China

Contacts

Public ContactLili Li

The Third Affiliated Hospital of Sun Yat sen University

22017377@qq.com+86 189 2508 7035

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026